Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Japan Tobacco Inc. | JAT | Nov 22, 2024 | 25.58 | +0.04 |
Japan Tobacco Inc. | JATA | Nov 22, 2024 | 12.40 | -2.36 |
JAPFA COMFEED RP 200 | 1JC1 | 0.00 | 0.00 | |
Japfa Ltd | 1O4 | Nov 22, 2024 | 0.25 | +0.82 |
Jardine Cycle & Carriage Limited | CYC | Nov 22, 2024 | 19.90 | +0.51 |
Jardine Matheson Holdings Ltd. | H4W | Nov 22, 2024 | 40.60 | +0.50 |
Jasmine International Public Co Ltd | JASN | Nov 22, 2024 | 0.06 | +17.02 |
Jastrzebska Spolka Weglowa S.A. | J2S | Nov 22, 2024 | 5.66 | +1.33 |
Jatcorp Limited | 3J2 | Nov 22, 2024 | 0.25 | -4.55 |
Jaywing Plc | D6BE | Nov 22, 2024 | 0.01 | 0.00 |
Jazz Pharmaceuticals plc - Ordinary Shares | J7Z | Nov 22, 2024 | 121.15 | +1.85 |
JB HI-FI | JB3 | Nov 22, 2024 | 55.50 | +1.83 |
JBG SMITH Properties | JBG | Nov 22, 2024 | 14.40 | +1.41 |
JBS SA | YJ3A | Nov 22, 2024 | 11.60 | +4.50 |
JCDecaux SA | DCS | Nov 22, 2024 | 14.43 | +2.20 |
JCDECAUX SA ADR 1/2/O.N. | DCS0 | Nov 22, 2024 | 6.55 | -1.50 |
JCR PHARM. | JCR | Nov 22, 2024 | 4.36 | 0.00 |
JD HEALTH INTERN. INC. | 8ZN0 | Nov 22, 2024 | 3.14 | -5.42 |
JD HEALTH INTL INC Ordinary Shares | 8ZN | Nov 22, 2024 | 3.30 | -4.62 |
JD Logistics Inc | 822 | Nov 22, 2024 | 1.60 | -3.61 |
JD Sports Fashion PLC | 9JD | Nov 22, 2024 | 1.13 | -3.42 |
JD.com Inc | 013C | Nov 22, 2024 | 16.58 | -1.53 |
JD.com, Inc. - American Depositary Shares | 013A | Nov 22, 2024 | 33.75 | -0.15 |
JD.COM. INC. RMBORDSHS | 013 | Nov 22, 2024 | 17.20 | +6.17 |
JDC Corporation | JDD | Nov 22, 2024 | 3.08 | +0.65 |
JDC Group AG | JDC | Nov 22, 2024 | 23.50 | +2.17 |
JDE Peet`s N.V. | JDE | Nov 22, 2024 | 18.63 | +1.14 |
Jefferies Financial Group Inc. | LN3 | Nov 22, 2024 | 75.30 | +6.18 |
JELD-WEN Holding, Inc. | 0JW | Nov 22, 2024 | 10.30 | +3.52 |
Jenoptik AG | JEN | Nov 22, 2024 | 21.12 | +0.57 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.